new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




  

Dharmacon Inc patents

Recent patent applications related to Dharmacon Inc. Dharmacon Inc is listed as an Agent/Assignee. Note: Dharmacon Inc may have other listings under different names/spellings. We're not affiliated with Dharmacon Inc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "D" | Dharmacon Inc-related inventors




Date Dharmacon Inc patents (updated weekly) - BOOKMARK this page
08/14/14Sirna targeting catenin, beta-1 (ctnnb1)
08/29/13Sirna targeting apolipoprotein b (apob)
08/29/13Sirna targeting cyclin-dependent kinase inhibitor 1b (p27, kip1) (cdkn1b)
08/22/13Modified cell lines for increasing lentiviral titers
08/15/13Sirna targeting myeloid differentiation primary response gene (88) (myd88)
03/07/13Sirna targeting fructose-1, 6-bisphosphatase 1 (fbp1)
01/24/13Sirna targeting beta secretase (bace)
12/20/12Duplex oligonucleotide complexes and methods for gene silencing by rna interference
11/08/12Sirna targeting amyloid beta (a4) precursor protein (app)
11/08/12Sirna targeting glucagon receptor (gccr)
10/25/12Sirna targeting diacylglycerol o-acyltransferase homolog 2 (dgat2)
10/25/12Sirna targeting apoliprotein (apob)
10/18/12Sirna targeting cyclin-dependent kinase inhibitor 1b (p27, kip1) (cdkn1b)
10/11/12Sirna targeting proto-oncogene met
10/11/12Sirna targeting kinase insert domain receptor (kdr)
10/11/12Duplex oligonucleotides with enhanced functionality in gene regulation
10/04/12Sirna targeting interleukin-1 receptor-associated kinase 4 (irak4)
08/30/12Sirna targeting catenin, beta-1 (ctnnb1)
07/19/12Sirna targeting connective tissue growth factor (ctgf)
05/31/12Sirna targeting spleen tyrosine kinase
05/31/12Sirna targeting catenin, beta-1 (ctnnb1)
04/05/12Modified cell lines for increasing lentiviral titers
03/15/12Sirna targeting apolipoprotein b (apob)
03/01/12Methods and compositions for selecting sirna of improved functionality
02/02/12Sirna targeting vegfa and methods for treatment in vivo
01/19/12Sirna targeting superoxide
01/12/12Sirna targeting myeloid differentiation primary response gene (88) (myd88)
12/29/11Sirna targeting histamine receptor h1
12/29/11Sirna targeting gremlin
12/29/11Sirna targeting cyclin-dependent kinase 4 (cdk4)
11/17/11Sirna targeting beta secretase (bace)
11/03/11Sirna targeting cyclin-dependent kinase inhibitor 1b (p27, kip1) (cdkn1b)
10/27/11Methods of modulating mesenchymal stem cell differentiation
07/14/11Minor groove binder (mgb)-oligonucleotide mirna antagonists
06/30/11Identification of mirna profiles that are diagnostic of hypertrophic cardiomyopathy
05/12/11Sirna targeting spleen tyrosine kinase
05/05/11Sirna targeting tnfa
03/31/11Sirna targeting tie-2
02/17/11Sirna targeting connective tissue growth factor (ctgf)
02/10/11Sirna targeting proto-oncogene met
01/27/11Sirna targeting amyloid beta (a4) precursor protein (app)
01/06/11Sirna targeting apolipoprotein b (apob)
01/06/11Sirna targeting beta secretase (bace)
12/30/10Sirna targeting survivin
12/23/10Sirna targeting tata box binding protein (tbp)-associated factor (taf1)
11/18/10Methods and compositions for selecting sirna of improved functionality
11/18/10Micro-rna scaffolds and non-naturally occurring micro-rnas
11/04/10Sirna targeting interleukin-1 receptor-associated kinase 4(irak4)
10/28/10Screening of micro-rna cluster inhibitor pools
10/21/10Sirna targeting kras
10/21/10Sirna targeting cyclin dependent kinase 11 (cdk11)
10/07/10Micro-rna scaffolds, non-naturally occurring micro-rnas, and methods for optimizing non-naturally occurring micro-rnas
09/30/10Sirna targeting ribonucleotide reductase m2 polypeptide (rrm2 or rnr-r2)
09/23/10Sirna targeting glucagon receptor (gcgr)
09/16/10Sirna targeting gremlin
09/16/10Sirna target hypoxia-inducible factor 1
08/26/10Novel chromophoric silyl protecting groups and their use in the chemical synthesis of oligonucleotides
08/05/10Modified polynucleotides for use in rna interference
07/29/10Sirna targeting diacylglycerol o-acyltransferase homolog 2 (dgat2)
07/22/10Compositions and methods for inhibiting gene silencing by rna interference
06/17/10Sirna targeting bcl2l1
06/10/10Sirna targeting serine/threonine kinase 12 (stk12 or aurora b kinase)
06/10/10Sirna targeting nucleoporin 62kda (nup62)
05/06/10Sirna targeting connective tissue growth factor (ctgf)
05/06/10Sirna targeting vascular endothelial growth factor (vegf)
Patent Packs
05/06/10Sirna targeting myeloid differentiation primary response gene (88) (myd88)
05/06/10Sirna targeting beta secretase (bace)
04/22/10Sirna targeting fructose-1, 6-bisphosphatase 1 (fbp1)
04/15/10Tripartite oligonucleotide complexes and methods for gene silencing by rna interference
04/08/10Sirna targeting spleen tyrosine kinase
04/08/10Sirna targeting superoxide dismutase 1 (sod1)
03/25/10Sirna targeting tata box binding protein (tbp)-associated factor (taf1)
03/18/10Sirna targeting proto-oncogene met
03/18/10Sirna targeting amyloid beta (a4) precursor protein (app)
03/11/10Sirna targeting tie-2
03/04/10Sirna targeting coatomer protein complex, subunit beta 2 (cpob2)
02/25/10Sirna targeting tumor protein 53 (p53)
02/04/10Sirna targeting survivin
01/28/10Sirna targeting ras-related nuclear protein ran
01/28/10Sirna targeting kinase insert domain receptor (kdr)
Patent Packs
01/21/10Sirna targeting cyclin-dependent kinase inhibitor 1b (p27, kip1) (cdkn1b)
01/21/10Sirna targeting histamine receptor h1
01/14/10Sirna targeting hypoxia-inducible factor 1
01/07/10Sirna targeting myeloid cell leukemia sequence 1
01/07/10Sirna targeting polo-like kinase-1 (plk-1)
12/31/09Sirna targeting interleukin-1 receptor-associated kinase 4 (irak4)
12/03/09Sirna targeting kras
11/26/09Sirna targeting transducin (beta)-like 3 (tbl3)
11/12/09Sirna targeting v-myc myelocytomatosis viral oncogene homolog (myc)
11/12/09Stabilized sirnas as transfection controls and silencing reagents
11/05/09Sirna targeting inner centromere protein antigens (incenp)
10/08/09Sirna targeting gremlin
09/10/09Sirna targeting connexin 43
09/03/09Microarray for detecting and quantifying microrna
08/20/09Duplex oligonucleotides with enhanced functionality in gene regulation
08/13/09Sirna targeting cyclin-dependent kinase 4 (cdk4)
07/30/09Sirna targeting connective tissue growth factor (ctgf)
07/16/09Sirna targeting phosphatases
06/25/09Sirna targeting tumor necrosis factor receptor superfamily member 1a
06/25/09Sirna targeting myeloid cell leukemia sequence 1
06/18/09Sirna targeting hypoxia-inducible factor 1
06/11/09Sirna targeting kras
05/07/09Sirna targeting nucleoporin 62kda (nup62)
04/02/09Sirna targeting transducin (beta)-like 3 (tbl3)
03/26/09Sirna targeting tata box binding protein (tbp)-associated factor (taf1)
03/12/09Sirna targeting inner centromere protein antigens (incenp)







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Dharmacon Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Dharmacon Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';